This week CDC discusses vaccine recommendations; a provider offers insights on administering live biotherapeutics; and early administration of simnotrelvir plus ritonavir shortened the time to sustained resolution of COVID-19 symptoms.
Israel’s Hepatitis C Elimination Program is Making Strides
World Hepatitis Day: Where Do We Go From Here?
Investigational Combination Hepatitis C Therapy Demonstrates a 97% Sustained Virologic Response
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Study Finds Association Between Illicit Fentanyl Use and Increased Risk of Hepatitis C
Efficacy of 8-Week Daclatasvir-Sofosbuvir Regimen for Chronic Hepatitis C